26 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2024.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Apellis Pharmaceuticals, Inc.'s own public LCA filings (FY2022–FY2024) — the same records an investigator pulls first.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Median offered wage is 18% above the DOL prevailing wage across 18 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Apellis Pharmaceuticals, Inc. sponsors H-1B workers, with 26 certified LCAs on file (FY2021–FY2024), including 4 in FY2024. The median certified salary is $147,659 (P25 $130,000, P75 $178,970). With a 63% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.
Apellis Pharmaceuticals, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2024).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 77% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 8 | 0 | 4 | 12 |
| FY2022 | 8 | 0 | 0 | 8 |
| FY2023 | 6 | 0 | 0 | 6 |
| FY2024 | 4 | 0 | 0 | 4 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Senior Business Analyst, Business Intelligence I-200-24114-917253 | $120,994/yr | III | Waltham, MA | Apr 23, 2024 | Certified |
Scientist, In Vitro Pharmacology I-200-24114-917246 | $120,800/yr | II | Watertown, MA | Apr 23, 2024 | Certified |
Principal Biostatistician I-200-24114-917264 | $154,400/yr | IV | Louisville, KY | Apr 23, 2024 | Certified |
Manager, Regulatory Information Management I-200-24108-896657 | $130,000/yr | III | Alpharetta, GA | Apr 17, 2024 | Certified |
Senior Manager, Distribution Operations I-200-23201-204623 | $150,000/yr | III | Okemos, MI | Jul 20, 2023 | Certified |
Regulatory Affairs Manager, Device I-200-23181-158840 | $140,000/yr | II | Waltham, MA | Jun 30, 2023 | Certified |
Regulatory Affairs Manager, Device I-200-23129-004633 | $140,000/yr | II | Waltham, MA | May 09, 2023 | Certified |
Associate Director, Biostatistics I-200-23128-002460 | $195,000/yr | III | Union City, CA | May 08, 2023 | Certified |
Manager, Regulatory Information Management I-200-23109-947885 | $130,000/yr | II | Bensalem, PA | Apr 19, 2023 | Certified |
Sr. Manager, Device and Adverse Event Reporting I-200-23089-891208 | $150,000/yr | III | Cinnaminson, NJ | Mar 30, 2023 | Certified |
Manager, Regulatory Systems Business Support I-200-22255-467705 | $125,000/yr | II | Waltham, MA | Sep 12, 2022 | Certified |
Associate Director, Regulatory Information Management I-200-22249-456035 | $180,294/yr | IV | Waltham, MA | Sep 06, 2022 | Certified |
Senior Specialist - Quality Assurance I-200-22142-198399 | $105,000/yr | III | Waltham, MA | May 22, 2022 | Certified |
Clinical Scientist, Opthalmology I-200-22116-107867 | $135,000/yr | II | Waltham, MA | Apr 26, 2022 | Certified |
Director, Global Business Intelligence I-200-22035-877447 | $215,000/yr | IV | Waltham, MA | Feb 03, 2022 | Certified |
Senior Director, Clinical Pharmacology I-200-22024-848107 | $240,000/yr | IV | Waltham, MA | Jan 24, 2022 | Certified |
Associate Director, Statistical Programming I-200-21335-735488 | $185,000/yr | IV | Waltham, MA | Dec 01, 2021 | Certified |
Principal Biostatistician I-200-21313-694920 | $147,659/yr | IV | The Colony, TX | Nov 09, 2021 | Certified |
Principal Biostatistician I-200-21180-431630 | $147,659/yr | IV | Downingtown, PA | Jun 29, 2021 | Certified |
QA Manager - Finished Goods I-200-21173-419436 | $135,000/yr | III | Waltham, MA | Jun 22, 2021 | Certified |
Associate Director of Biostatistics I-200-21035-055945 | $175,000/yr | IV | Waltham, MA | Feb 04, 2021 | Certified |
Associate Director of Biostatistics I-200-21035-055816 | $150,000/yr | IV | Waltham, MA | Feb 04, 2021 | Withdrawn |
Head of Financial Planning & Analysis I-200-21027-037377 | $250,000/yr | IV | Waltham, MA | Jan 27, 2021 | Certified |
Sr. Associate, Global Regulatory Operations I-200-21007-000224 | $100,000/yr | III | Waltham, MA | Jan 07, 2021 | Certified |
Sr. Associate, Global Regulatory Operations I-200-21006-997771 | $100,000/yr | III | Waltham, MA | Jan 06, 2021 | Withdrawn |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2024 disclosure records.
Most active filing months: Jan and Apr — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
8 states · 10 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →